Anbio Biotechnology (NNNN) Prepaid Assets (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Prepaid Assets of $14.1 million for Q4 2025, up 147.73% year-over-year from $5.7 million in Q4 2024, and down 100.0% quarter-over-quarter from $10173.1 billion in Q2 2025.
Anbio Biotechnology (NNNN) Prepaid Assets (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Prepaid Assets for 3 consecutive years, with $14.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 147.73% year-over-year to $14.1 million; the TTM figure through Dec 2025 stood at $14.1 million (up 147.73% YoY), while the FY2025 annual figure was $14.1 million, up 147.73% from the prior year.
- Prepaid Assets fell to $14.1 million in Q4 2025 per NNNN's latest filing, from $10173.1 billion in the prior quarter.
- Across five years, Prepaid Assets topped out at $10173.1 billion in Q2 2025 and bottomed at $403868.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $2543.3 billion across 3 years, with a median of $9.9 million in 2024.
- Annual changes were most pronounced in 2024 — Prepaid Assets jumped 1307.16% — and 2025, when it surged 147.73%.
- Anbio Biotechnology's Prepaid Assets stood at $403868.0 in 2023, then surged by 1307.16% to $5.7 million in 2024, then surged by 147.73% to $14.1 million in 2025.
- Business Quant data shows NNNN's Prepaid Assets at $14.1 million in Q4 2025, $10173.1 billion in Q2 2025, and $5.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Anbio Biotechnology | 301.77 Mn | 289.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.08 Mn |
| Jun 30, 2025 | 10,173.06 Bn |
| Dec 31, 2024 | 5.68 Mn |
| Dec 31, 2023 | 403,868.00 |